Name
ApconiX Ltd.
What We Do
ApconiX are experts in cardiac and CNS electrophysiology, target safety assessments and in all aspects of nonclinical toxicology and DMPK project support. ApconiX was formed with the objective to give companies of all sizes access to the breadth and depth of safety expertise generally only available in large pharma.
Our lab team conduct hERG and CiPA cardiac screening assays and have developed an in vitro assay to better understand seizure liability (iSLA®). We continue to carry out research in other fields relevant to efficacy and safety in the CNS.
The ApconiX Safety Science Team combines toxicology expertise and advanced data science, offering customized Acuity® target safety assessments (TSAs). The team also conducts modality or asset focused reports and will support you in understanding and optimizing project safety profiles.
Our consultancy team provide a flexible nonclinical drug safety and DMPK support to your discovery and development team.
Our lab team conduct hERG and CiPA cardiac screening assays and have developed an in vitro assay to better understand seizure liability (iSLA®). We continue to carry out research in other fields relevant to efficacy and safety in the CNS.
The ApconiX Safety Science Team combines toxicology expertise and advanced data science, offering customized Acuity® target safety assessments (TSAs). The team also conducts modality or asset focused reports and will support you in understanding and optimizing project safety profiles.
Our consultancy team provide a flexible nonclinical drug safety and DMPK support to your discovery and development team.
Website
Product or Service Categories (15)
Pharmaceutical Toxicology, Regulatory Toxicology, Preclinical, Consulting/Professional Services, Safety/Risk Assessment